405 related articles for article (PubMed ID: 28302506)
1. Xanthine oxidase inhibitory activity of nicotino/isonicotinohydrazides: A systematic approach from in vitro, in silico to in vivo studies.
Zafar H; Hayat M; Saied S; Khan M; Salar U; Malik R; Choudhary MI; Khan KM
Bioorg Med Chem; 2017 Apr; 25(8):2351-2371. PubMed ID: 28302506
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, molecular docking and xanthine oxidase inhibitory activity of 5-aryl-1H-tetrazoles.
Fatima I; Zafar H; Khan KM; Saad SM; Javaid S; Perveen S; Choudhary MI
Bioorg Chem; 2018 Sep; 79():201-211. PubMed ID: 29772470
[TBL] [Abstract][Full Text] [Related]
3. Dinuclear Cyclam Complex as a Non-Cytotoxic, Anti-Hyperurecemic Lead: In vitro to In vivo Studies.
Zafar H; Hamdi N; Lachkar M; El Bali B; Khan A; Choudhary MI
Med Chem; 2017; 13(6):585-591. PubMed ID: 28290251
[TBL] [Abstract][Full Text] [Related]
4. Xanthine Oxidase Inhibitory and Molecular Docking Studies on Pyrimidones.
Zafar H; Iqbal S; Javaid S; Khan KM; Choudhary MI
Med Chem; 2018; 14(5):524-535. PubMed ID: 29189174
[TBL] [Abstract][Full Text] [Related]
5.
Gul A; Saad SM; Zafar H; Atia-Tul-Wahab ; Khan KM; Choudhary MI
Med Chem; 2023; 19(4):384-392. PubMed ID: 35726432
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of hydroxychalcones as multifunctional non-purine xanthine oxidase inhibitors for the treatment of hyperuricemia.
Xie Z; Luo X; Zou Z; Zhang X; Huang F; Li R; Liao S; Liu Y
Bioorg Med Chem Lett; 2017 Aug; 27(15):3602-3606. PubMed ID: 28655421
[TBL] [Abstract][Full Text] [Related]
7. 2-Benzamido-4-methylthiazole-5-carboxylic Acid Derivatives as Potential Xanthine Oxidase Inhibitors and Free Radical Scavengers.
Ali MR; Kumar S; Afzal O; Shalmali N; Ali W; Sharma M; Bawa S
Arch Pharm (Weinheim); 2017 Feb; 350(2):. PubMed ID: 28133790
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, structure-activity relationships, and mechanistic studies of 5-arylazo-tropolone derivatives as novel xanthine oxidase (XO) inhibitors.
Sato D; Kisen T; Kumagai M; Ohta K
Bioorg Med Chem; 2018 Jan; 26(2):536-542. PubMed ID: 29274704
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological evaluation of N-(3-cyano-1H-indol-5/6-yl)-6-oxo-1,6-dihydropyrimidine-4-carboxamides and 5-(6-oxo-1,6-dihydropyrimidin-2-yl)-1H-indole-3-carbonitriles as novel xanthine oxidase inhibitors.
Zhang B; Duan Y; Yang Y; Mao Q; Lin F; Gao J; Dai X; Zhang P; Li Q; Li J; Dai R; Wang S
Eur J Med Chem; 2022 Jan; 227():113928. PubMed ID: 34688012
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of novel xanthine oxidase inhibitors bearing a 2-arylbenzo[b]furan scaffold.
Tang HJ; Li W; Zhou M; Peng LY; Wang JX; Li JH; Chen J
Eur J Med Chem; 2018 May; 151():849-860. PubMed ID: 29684895
[TBL] [Abstract][Full Text] [Related]
11.
Mehmood A; Rehman AU; Ishaq M; Zhao L; Li J; Usman M; Zhao L; Rehman A; Zad OD; Wang C
Comb Chem High Throughput Screen; 2020; 23(9):917-930. PubMed ID: 32342806
[TBL] [Abstract][Full Text] [Related]
12. Computational Analysis and Synthesis of Syringic Acid Derivatives as Xanthine Oxidase Inhibitors.
Malik N; Khatkar A; Dhiman P
Med Chem; 2020; 16(5):643-653. PubMed ID: 31584375
[TBL] [Abstract][Full Text] [Related]
13. 3,4-Dihydroxy-5-nitrobenzaldehyde (DHNB) is a potent inhibitor of xanthine oxidase: a potential therapeutic agent for treatment of hyperuricemia and gout.
Lü JM; Yao Q; Chen C
Biochem Pharmacol; 2013 Nov; 86(9):1328-37. PubMed ID: 23994369
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of 1-alkyl-5/6-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-1H-indole-3-carbonitriles as novel xanthine oxidase inhibitors.
Gao J; Liu X; Zhang B; Mao Q; Zhang Z; Zou Q; Dai X; Wang S
Eur J Med Chem; 2020 Mar; 190():112077. PubMed ID: 32014678
[TBL] [Abstract][Full Text] [Related]
15. In vitro xanthine oxidase inhibitory and in vivo anti-hyperuricemic properties of sodium kaempferol-3'-sulfonate.
Wang X; Cui Z; Luo Y; Huang Y; Yang X
Food Chem Toxicol; 2023 Jul; 177():113854. PubMed ID: 37230458
[TBL] [Abstract][Full Text] [Related]
16. 3,5,2',4'-Tetrahydroxychalcone, a new non-purine xanthine oxidase inhibitor.
Niu Y; Zhu H; Liu J; Fan H; Sun L; Lu W; Liu X; Li L
Chem Biol Interact; 2011 Feb; 189(3):161-6. PubMed ID: 21167141
[TBL] [Abstract][Full Text] [Related]
17. Xanthine oxidase inhibitors beyond allopurinol and febuxostat; an overview and selection of potential leads based on in silico calculated physico-chemical properties, predicted pharmacokinetics and toxicity.
Šmelcerović A; Tomović K; Šmelcerović Ž; Petronijević Ž; Kocić G; Tomašič T; Jakopin Ž; Anderluh M
Eur J Med Chem; 2017 Jul; 135():491-516. PubMed ID: 28478180
[TBL] [Abstract][Full Text] [Related]
18. Potential anti-gout constituents as xanthine oxidase inhibitor from the fruits of Stauntonia brachyanthera.
Liu D; Wang D; Yang W; Meng D
Bioorg Med Chem; 2017 Jul; 25(13):3562-3566. PubMed ID: 28511908
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of novel 2-(indol-5-yl)thiazole derivatives as xanthine oxidase inhibitors.
Song JU; Choi SP; Kim TH; Jung CK; Lee JY; Jung SH; Kim GT
Bioorg Med Chem Lett; 2015 Mar; 25(6):1254-8. PubMed ID: 25704891
[TBL] [Abstract][Full Text] [Related]
20. Novel 3-[4-alkoxy-3-(1H-tetrazol-1-yl) phenyl]-1,2,4-oxadiazol-5(4H)-ones as promising xanthine oxidase inhibitors: Design, synthesis and biological evaluation.
Gao J; Zhang Z; Zhang B; Mao Q; Dai X; Zou Q; Lei Y; Feng Y; Wang S
Bioorg Chem; 2020 Jan; 95():103564. PubMed ID: 31927335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]